An Ocrevus Patient Dies of PML. Need we Worry?
The journal JAMA Neurology recently reported that a 78-year-old man with progressive multiple sclerosis died after being diagnosed with the brain disease progressive multifocal leukoencephalopathy (PML). The man, diagnosed with MS about 30 years ago, had been treated for two years with Ocrevus (ocrelizumab), and had no previous immunotherapy. As of last December, 10 cases of PML had been reported in people being treated with Ocrevus since the U.S. Food…Continue Reading